scispace - formally typeset
H

Helen Findlow

Researcher at Manchester Royal Infirmary

Publications -  58
Citations -  1409

Helen Findlow is an academic researcher from Manchester Royal Infirmary. The author has contributed to research in topics: Vaccination & Meningococcal vaccine. The author has an hindex of 18, co-authored 58 publications receiving 1303 citations. Previous affiliations of Helen Findlow include University of London & University of Manchester.

Papers
More filters
Journal ArticleDOI

Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine

TL;DR: Additional booster doses of the MCC vaccine may be required in the future to maintain good antibody levels; however, there is no immediate need for a booster during adolescence, as mathematical modeling has shown that persisting herd immunity is likely to control disease for a number of years.
Journal ArticleDOI

Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom.

TL;DR: It is demonstrated that NeisVac-C and Menjugate generate good immunogenicity after the first dose at 2 months of age when coadministered with PCV7 and Pediacel and merit further investigation in single-dose priming strategies.
Journal ArticleDOI

The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine

TL;DR: The prevalence of meningococcal carriage in the African meningitis belt is lower than in industrialized countries and is very diverse and dynamic, even in the absence of vaccination.